An Exploratory Phase 1 Microdose Study of PRX-105

Clinical trial NCT01093859 · COMPLETED

Trial details

NCT number: NCT01093859
Sponsor: Protalix
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Organophosphate Exposure

Start date: 2010-03-01
Primary completion: 2010-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.